{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:30:50Z","timestamp":1766503850037},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s13312-017-0996-3","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:45:16Z","timestamp":1484268316000},"page":"49-50","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Repeated administrations of rituximab along with steroids and immunosuppressive agents in refractory steroid-resistant nephrotic syndrome"],"prefix":"10.1007","volume":"54","author":[{"given":"Shuichiro","family":"Fujinaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sakuraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,14]]},"reference":[{"key":"996_CR1","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1056\/NEJMc063706","volume":"356","author":"A Bagga","year":"2007","unstructured":"Bagga A, Sinha A, Moudgil A. Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med. 2007;356:2751\u20132.","journal-title":"N Engl J Med."},{"key":"996_CR2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00467-011-1778-0","volume":"26","author":"JA Kari","year":"2011","unstructured":"Kari JA, El-Morshedy SM, El-Desoky S, Alshaya HO, Rahim KA, Edrees BM. Rituximab for refractory cases of childhood nephrotic syndrome. Pediatr Nephrol. 2011;26:733\u20137.","journal-title":"Pediatr Nephrol."},{"key":"996_CR3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2011080775","volume":"23","author":"A Magnasco","year":"2012","unstructured":"Magnasco A, Ravani P, Edefonti A, Murer L, Ghio L, Belingheri M, et al. Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol. 2012;23:1117\u201324.","journal-title":"J Am Soc Nephrol."},{"key":"996_CR4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2215\/CJN.00570109","volume":"4","author":"G Fernandez-Fresnedo","year":"2009","unstructured":"Fernandez-Fresnedo G, Segarra A, Gonz\u00e1lez E, Alexandru S, Delgado R, Ramos N, et al. Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2009;4:1317\u201323.","journal-title":"Clin J Am Soc Nephrol."},{"key":"996_CR5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","volume":"24","author":"K Kamei","year":"2009","unstructured":"Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M, et al. Single dose of rituximab for refractory steroiddependent nephrotic syndrome in children. Pediatr Nephrol. 2009;24:1321\u20138.","journal-title":"Pediatr Nephrol."},{"key":"996_CR6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-009-1377-5","volume":"25","author":"S Fujinaga","year":"2010","unstructured":"Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, et al. Single infusion of rituximab for persistent steroiddependent minimal-change nephrotic syndrome after longterm cyclosporine. Pediatr Nephrol. 2010;25:539\u20134.","journal-title":"Pediatr Nephrol."},{"key":"996_CR7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00467-015-3120-8","volume":"30","author":"CE Counsilman","year":"2015","unstructured":"Counsilman CE, Jol-van der Zijde CM, Stevens J, Cransberg K, Bredius RG, Sukhai RN. Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome. Pediatr Nephrol. 2015;30:1367\u201370.","journal-title":"Pediatr Nephrol."},{"key":"996_CR8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5414\/CN108835","volume":"85","author":"S Fujinaga","year":"2016","unstructured":"Fujinaga S, Ozawa K, Sakuraya K, Yamada A, Shimizu T. Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome. Clin Nephrol. 2016;85:340\u20135.","journal-title":"Clin Nephrol."}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-017-0996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13312-017-0996-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-017-0996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:08:51Z","timestamp":1498363731000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13312-017-0996-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["996"],"URL":"https:\/\/doi.org\/10.1007\/s13312-017-0996-3","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}